Related Experiment Video
Updated: Jan 20, 2026

09:03
Forward Genetic Approaches in Chlamydia trachomatis
Published on: October 23, 2013
13.3K
Expert Interviews on Multilevel Barriers in Implementing Expedited Partner Therapy for Chlamydia
Megan McCool-Myers1, Akimi Dan-Yei Smith, Melissa J Kottke
1Jane Fonda Center for Adolescent Reproductive Health, Emory University School of Medicine, Atlanta, Georgia.
Journal of Public Health Management and Practice : JPHMP
|August 16, 2019
Summary
Expedited partner therapy (EPT) for chlamydia is underutilized due to many barriers. Addressing issues like liability, funding, and awareness is crucial for successful implementation and preventing reinfection.
Area of Science:
- Public Health
- Infectious Disease Control
- Health Policy
Background:
- Expedited partner therapy (EPT) is an evidence-based strategy to treat chlamydia infections in partners without prior medical evaluation.
- EPT aims to improve treatment adherence and prevent chlamydial reinfection in index patients.
- Despite its benefits, EPT implementation faces significant multilevel barriers.
Purpose of the Study:
- To identify and categorize barriers to the implementation of expedited partner therapy (EPT) across the United States.
- To understand the perspectives of EPT experts on challenges hindering widespread adoption.
Main Methods:
- Qualitative interviews were conducted with 11 EPT experts nationwide.
- Barriers identified through interviews were thematically analyzed and categorized.
Main Results:
- Thirty-four distinct barriers to EPT implementation were identified.
- Key themes included liability and adverse events, funding issues, electronic medical record integration challenges, and lack of awareness among healthcare providers and pharmacists.
Conclusions:
- Multilevel barriers significantly impede the utilization of expedited partner therapy (EPT).
- Targeted strategies are necessary to enhance awareness, secure funding, and optimize healthcare system processes for effective EPT implementation.
More Related Videos
Related Concept Videos
Bacterial Phylum Chlamydiae
435
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
435
Nursing Implementation
6.0K
Implementation is the execution of the nursing care plan developed during the planning phase.
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
6.0K
Physiological Barriers
5.1K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.1K
Gene Therapy
27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Mucosal Barrier of the Stomach
2.1K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.1K
Surface Membrane Barriers
2.6K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
2.6K

